H Fuchssteiner

555 total citations
7 papers, 77 citations indexed

About

H Fuchssteiner is a scholar working on Genetics, Epidemiology and Gastroenterology. According to data from OpenAlex, H Fuchssteiner has authored 7 papers receiving a total of 77 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 4 papers in Epidemiology and 3 papers in Gastroenterology. Recurrent topics in H Fuchssteiner's work include Inflammatory Bowel Disease (6 papers), Microscopic Colitis (4 papers) and Gastrointestinal Tumor Research and Treatment (1 paper). H Fuchssteiner is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Microscopic Colitis (4 papers) and Gastrointestinal Tumor Research and Treatment (1 paper). H Fuchssteiner collaborates with scholars based in Austria, Germany and Estonia. H Fuchssteiner's co-authors include Michael Gschwantler, Dietmar Hübner, H Schwaighofer, Christian Datz, A Maieron, Andreas Püspök, E Dulic-Lakovic, Thomas Haas, H Gröchenig and Andreas Mayer and has published in prestigious journals such as Gastroenterology, Gastrointestinal Endoscopy and Zeitschrift für Gastroenterologie.

In The Last Decade

H Fuchssteiner

6 papers receiving 75 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Fuchssteiner Austria 3 62 58 13 10 8 7 77
Fernando Alberca Spain 3 28 0.5× 36 0.6× 10 0.8× 5 0.5× 3 0.4× 12 47
Yu Kar Ling Koda Brazil 5 47 0.8× 27 0.5× 9 0.7× 28 2.8× 19 2.4× 6 68
Daniel Agardh Sweden 4 19 0.3× 35 0.6× 15 1.2× 8 0.8× 9 1.1× 7 49
Deepa Rattehalli United Kingdom 4 24 0.4× 27 0.5× 7 0.5× 9 0.9× 8 1.0× 9 42
T. Dao France 4 28 0.5× 51 0.9× 18 1.4× 3 0.3× 15 1.9× 7 64
Corinne Borderon France 3 13 0.2× 41 0.7× 28 2.2× 10 1.0× 9 1.1× 4 53
Mohamed Moftah Ireland 5 16 0.3× 55 0.9× 6 0.5× 14 1.4× 7 0.9× 11 65
Constanza Ciriza de los Ríos Spain 5 15 0.2× 76 1.3× 14 1.1× 2 0.2× 3 0.4× 9 85
Vincent Quentin France 5 39 0.6× 36 0.6× 9 0.7× 3 0.4× 7 53
Fatemeh Farahmand Iran 7 37 0.6× 55 0.9× 8 0.8× 13 1.6× 13 80

Countries citing papers authored by H Fuchssteiner

Since Specialization
Citations

This map shows the geographic impact of H Fuchssteiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Fuchssteiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Fuchssteiner more than expected).

Fields of papers citing papers by H Fuchssteiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Fuchssteiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Fuchssteiner. The network helps show where H Fuchssteiner may publish in the future.

Co-authorship network of co-authors of H Fuchssteiner

This figure shows the co-authorship network connecting the top 25 collaborators of H Fuchssteiner. A scholar is included among the top collaborators of H Fuchssteiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Fuchssteiner. H Fuchssteiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Blesl, Andreas, Christoph Högenauer, Robert Koch, et al.. (2019). Stellenwert von Vedolizumab als Erstlinienbiologikum bei chronisch-entzündlichen Darmerkrankungen (CED). 17(1). 10–17. 1 indexed citations
2.
Miehsler, Wolfgang, Clemens Dejaco, H Gröchenig, et al.. (2018). Zweiter österreichischer Konsensus zur sicheren Anwendung von anti-TNF-α-Antikörpern bei chronisch-entzündlichen Darmerkrankungen. Zeitschrift für Gastroenterologie. 56(3). 275–302.
3.
Gröchenig, H, Clemens Dejaco, T Feichtenschlager, et al.. (2016). Use and predictors of complementary and alternative medicine (CAM) in patients with inflammatory bowel disease – results of a multicenter study of the Austrian IBD Study Group (ATISG). Zeitschrift für Gastroenterologie. 54(5). 1 indexed citations
5.
Angelberger, Sieglinde, Christoph Campregher, H Fuchssteiner, et al.. (2013). Kolorektales Karzinom: Screening und Surveillance bei chronisch entzündlichen Darmerkrankungen − Konsensus der Arbeitsgruppe für chronisch entzündliche Darmerkrankungen der ÖGGH. Zeitschrift für Gastroenterologie. 51(5). 450–457. 1 indexed citations
6.
Dulic-Lakovic, E, Dietmar Hübner, H Fuchssteiner, et al.. (2011). Bleeding Dieulafoy lesions of the small bowel: a systematic study on the epidemiology and efficacy of enteroscopic treatment. Gastrointestinal Endoscopy. 74(3). 573–580. 61 indexed citations
7.
Novacek, Gottfried, Anna Sobala, Wolfgang Petritsch, et al.. (2008). W1138 A Nationwide Multicenter Study On Venous Thromboembolism in Inflammatory Bowel Disease. Gastroenterology. 134(4). A–641. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026